Metformin therapy increases leukocyte telomere length, telomerase activity, and longevity gene expression in Asian Indians with prediabetes: A 24-week participant-blind, outcome-assessor-blinded randomized controlled trial.

Bhatt SP, Pandey S, Misra A

Open source

DOI
10.1016/j.mad.2026.112241
Published
2026 Sep 3
Container
Mechanisms of ageing and development
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mad.2026.112241,
  title = {Metformin therapy increases leukocyte telomere length, telomerase activity, and longevity gene expression in Asian Indians with prediabetes: A 24-week participant-blind, outcome-assessor-blinded randomized controlled trial.},
  author = {Bhatt SP and Pandey S and Misra A},
  year = {2026},
  journal = {Mechanisms of ageing and development},
  doi = {10.1016/j.mad.2026.112241},
  url = {https://doi.org/10.1016/j.mad.2026.112241}
}

RIS

TY  - JOUR
TI  - Metformin therapy increases leukocyte telomere length, telomerase activity, and longevity gene expression in Asian Indians with prediabetes: A 24-week participant-blind, outcome-assessor-blinded randomized controlled trial.
AU  - Bhatt SP
AU  - Pandey S
AU  - Misra A
PY  - 2026
JO  - Mechanisms of ageing and development
DO  - 10.1016/j.mad.2026.112241
UR  - https://doi.org/10.1016/j.mad.2026.112241
ER  - 

APA

SP, B., S, P., & A, M. (2026). Metformin therapy increases leukocyte telomere length, telomerase activity, and longevity gene expression in Asian Indians with prediabetes: A 24-week participant-blind, outcome-assessor-blinded randomized controlled trial.. Mechanisms of ageing and development. https://doi.org/10.1016/j.mad.2026.112241

Source records